GLMD - Galmed Pharmaceuticals Ltd - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GLMD is currently covered by 1 analysts with an average price target of $716.3. This is a potential upside of $713.55 (25947.27%) from yesterday's end of day stock price of $2.75.

Galmed Pharmaceuticals Ltd's activity chart (see below) currently has 11 price targets and 25 ratings on display. The stock rating distribution of GLMD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 38.89% with an average time for these price targets to be met of 367.78 days.

Highest price target for GLMD is $15, Lowest price target is $15, average price target is $716.3.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 24-Jul-2023. First documented stock forecast 08-Jul-2015.

Currently out of the existing stock ratings of GLMD, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$48

$45.07 (1538.23%)

1 years 3 months 29 days ago
(24-Jul-2023)

1/2 (50%)

$33.48 (230.58%)

89

Buy

2 years 3 months 14 days ago
(08-Aug-2022)

0/2 (0%)

$4172.4 (398.28%)

Buy

$13

2 years 3 months 18 days ago
(04-Aug-2022)

2/2 (100%)

$-34.55 (-72.66%)

291

Hold

2 years 6 months 4 days ago
(18-May-2022)

1/2 (50%)

$-541.2 (-59.07%)

580

Hold

2 years 6 months 4 days ago
(18-May-2022)

1/2 (50%)

$1481.4 (84.24%)

2101

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GLMD (Galmed Pharmaceuticals Ltd) average time for price targets to be met?

On average it took 367.78 days on average for the stock forecasts to be realized with a an average price target met ratio 38.89

Which analyst has the current highest performing score on GLMD (Galmed Pharmaceuticals Ltd) with a proven track record?

JASON KOLBERT

Which analyst has the current lower performing score on GLMD (Galmed Pharmaceuticals Ltd) with a proven track record?

ED ARCE

Which analyst has the most public recommendations on GLMD (Galmed Pharmaceuticals Ltd)?

Jason Kolbert works at DAWSON JAMES and has 3 price targets and 8 ratings on GLMD

Which analyst is the currently most bullish on GLMD (Galmed Pharmaceuticals Ltd)?

Elemer Piros with highest potential upside - $58.58

Which analyst is the currently most reserved on GLMD (Galmed Pharmaceuticals Ltd)?

Jason Kolbert with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?